Associate Professor of Medicine, Johns Hopkins University School of Medicine
Cardiology
Dr. Erin D. Michos, MD
|
|
Give Review
Doctor Erin D. Michos, MD is an expert in the field of Cardiology. She attended Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine has a rank of 19 in research and a 29 in primary care She has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Erin Michos is also a published MD. She has 75 paper published. The most recent paper is: Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: The Very Large Database of Lipids (VLDL-3) study. She accepts Medicare.
Publications
- The Association of Resting Heart Rate and Incident Hypertension: The Henry Ford Hospital Exercise Testing (FIT) Project.
- 25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension - Is it worth the "hype"?
- Parathyroid hormone and the risk of incident Hypertension: the Atherosclerosis Risk in Communities study.
- Serum 25-hydroxyvitamin D and the incidence of Atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.
- MY APPROACH to using Coronary artery calcium scoring in primary prevention of atherosclerotic cardiovascular disease.
- Preventing cardiovascular Disease in patients with diabetes: use of aspirin for primary prevention.
- The 25-hydroxyvitamin D3 C-3 epimer: Distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Commu...
- Relation of Resting Heart Rate to Risk for All-Cause Mortality by Gender After considering Exercise Capacity (the Henry Ford Exercise Testing Project).
- Use of lipoprotein particle measures for assessing coronary Heart disease risk post-American Heart Association/American College of Cardiology guidelines: the Multi-Eth...
- Temporal Trends in the Occurrence and Outcomes of Atrial Fibrillation in Patients With Acute Myocardial Infarction (from the Atherosclerosis Risk in Communities Survei...
- Parathyroid hormone concentration and risk of cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) study.
- Headed in the Right Direction But at Risk for Miscalculation: A Critical Appraisal of the 2013 ACC/AHA Risk Assessment Guidelines.
- Serum magnesium, phosphorus, and calcium are associated with risk of incident Heart failure: the Atherosclerosis Risk in Communities (ARIC) Study.
- 2013 ACC/AHA Cholesterol Treatment Guideline: What Was Done Well and What Could Be Done Better.
- Vitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC Brain MRI Study.
- Vitamin D and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities Brain Magnetic Resonance Imaging Study.
- Serum phosphate is associated with Aortic valve calcification in the Multi-ethnic Study of Atherosclerosis (MESA).
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk.
- Physical Environment May Modify the Association Between Depressive Symptoms and Change in Waist Circumference: The Multi-Ethnic Study of Atherosclerosis.
- Association Between Resting Heart Rate and Inflammatory Biomarkers (High-Sensitivity C-Reactive Protein, Interleukin-6, and Fibrinogen) (from the Multi-Ethnic Study of...
- Very Large Database of Lipids: Rationale and Design.
- Niacin--a case study for the role of event-driven versus surrogate endpoint trials.
- Echoing the Appropriate Use Criteria: The Role of Echocardiography for Cardiovascular Risk Assessment of the Asymptomatic Individual.
- Pulmonary Hyperinflation and Left Ventricular Mass.
- Neighborhood health-promoting resources and obesity risk (the multi-ethnic study of atherosclerosis).
- Impact of Fitness Versus Obesity on Routinely Measured Cardiometabolic Risk in Young, Healthy Adults.
- Vitamin D, calcium, and atherosclerotic risk: evidence from serum levels and supplementation studies.
- C-reactive protein level and the incidence of eligibility for statin therapy: the multi-ethnic study of atherosclerosis.
- Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the Meantime, Some Challenges and Recommendations.
- Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events: Reconciling the AIM-HIGH (Atherothrombosis Interv...
- 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files.
- Making the case for selective use of statins in the primary prevention setting.
- Comparison of the racial/ethnic prevalence of regular aspirin use for the primary prevention of coronary Heart disease from the multi-ethnic study of atherosclerosis.
- Should statin therapy be allocated on the basis of global risk or on the basis of randomized trial evidence?
- Comparison of the Framingham Heart Study hypertension model with blood pressure alone in the prediction of risk of hypertension: the Multi-Ethnic Study of Atherosclero...
- Sex steroid hormone concentrations and risk of death in US men.
- 25-hydroxyvitamin D levels, race, and the progression of kidney Disease.
- The HALTS trial--halting atherosclerosis or halted too early?
- Vitamin D status and cardiometabolic risk factors in the United States adolescent population.
- 25-hydroxyvitamin D levels inversely associate with risk for developing Coronary artery calcification.
- Diet soda intake and risk of incident metabolic Syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA).
- Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the...
- Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular Disease or C-reactive protein in the old order amish.
- Factors associated with low levels of subclinical vascular Disease in older adults: multi-ethnic study of atherosclerosis.
- Coronary artery calcification and inflammation according to various metabolic syndrome definitions.
- Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial Disease.
- 25-hydroxyvitamin D levels and the risk of mortality in the general population.
- High prevalence of cardiometabolic risk factors in women considered low risk by traditional risk assessment.
- Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial Disease: results from NHANES 2001 to 2004.
- Favorable cardiovascular risk factor profile is associated with reduced prevalence of Coronary artery calcification and inflammation in asymptomatic nondiabetic white ...
- Vitamin D supplementation and cardiovascular Disease risk.
- Further improvements in CHD risk prediction for women.
- Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions.
- Comparison of Coronary calcium and stress myocardial perfusion imaging in apparently healthy siblings of individuals with premature Coronary artery disease.
- Women with a low Framingham risk score and a family history of premature coronary Heart disease have a high prevalence of subclinical coronary atherosclerosis.
- Detection of high-risk young adults and women by Coronary calcium and National Cholesterol Education Program Panel III guidelines.
- Relation of family history of premature coronary Heart disease and metabolic risk factors to risk of coronary arterial calcium in asymptomatic subjects.
- Coronary artery calcification and family history of premature coronary Heart disease: sibling history is more strongly associated than parental history.
- Prediction of Coronary artery calcium progression in individuals with low framingham risk score: the multi-ethnic study of atherosclerosis.
- Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention.
- Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly.
- Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women.
- Rosuvastatin is similarly effective for primary prevention of cardiovascular Disease in women as in men.
- Vitamin D in atherosclerosis, vascular Disease, and endothelial function.
- The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences.
- Serum vitamin D, parathyroid hormone levels, and Carotid atherosclerosis.
- Vitamin D deficiency and the risk of incident Type 2 diabetes.
- Vitamin D and cardiovascular Disease risk.
- Sex hormones, sex hormone binding globulin, and abdominal Aortic calcification in women and men in the multi-ethnic study of atherosclerosis (MESA).
- Evidence-based guidelines for cardiovascular Disease prevention in women: 2007 update.
- Current guidelines for high-density lipoprotein cholesterol in therapy and future directions.
- Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: The Very Large Database of Lipids (VLDL-3) study.
- mActive: A Randomized Clinical Trial of an Automated mHealth Intervention for Physical Activity Promotion.
- Fibroblast growth factor-23 and incident coronary Heart disease, Heart failure, and cardiovascular mortality: the atherosclerosis risk in communities study.
Schools
Northwestern Center Feinberg School of Medicine
Johns Hopkins Hospital
Procedures Preformed
- Cardiac Imaging
- Peripheral Artery Catheterization
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Dissection
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Johns Hopkins Bloomberg School of Public Health -
Johns Hopkins University -
Northwestern University Feinberg School of Medicine
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1447300439 | |
| NPPES Provider LastName | MICHOS | |
| NPPES Provider FirstName | ERIN | |
| NPPES Provider ZIPCode | 212870001 | |
| NPPES Provider State | MD | |
| Specialty Description | Cardiology | |
| Total Claim Count | 78.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447300439 |
| Last Name Of The Provider | MICHOS |
| First Name Of The Provider | ERIN |
| View All |
Similar Doctors
|
|
Dr. Martin A. Albornoz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven Schulman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian G. Kral, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John A. Kiely, MD |
|
|
Dr. Michael Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven R. Jones, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas Traill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Faisal K. Siddiqi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohamad-Reza M. Sajadi, MD |
|
|
Dr. Evan K. Grove, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anupama K. Rao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunal S. Makadia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Myron Weisfeldt, MD
This Doctor is OpenDoctor Recommended.
|